Paul Liknaitzky Lab

Welcome to
The Clinical Psychedelic Research Lab

Australia's first psychedelic lab, establishing a rigorous program of research in psychedelic medicine at Monash University that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.

The Lab is led by Dr Paul Liknaitzky.

The Lab is part of the School of Psychological Sciences within the Turner Institute for Brain and Mental Health, and the Department of Psychiatry within the School of Clinical Sciences.

Latest announcement: Psilocybin has landed, PsiGAD-1 underway

May 2022: We recently received Australia's largest-ever shipment of clinical grade psilocybin. Many thanks to our partners at Usona Institute whose leading work has made this possible. With the arrival of this exciting package, treatment for the PsiGAD-1 Clinical Trial has commenced. Please email psilocybin@monash.edu for more information.